Telegram RegisterThe public register of Telegram
Telegram profile photo for MCQ HACK 🫡🔥

Channel

MCQ HACK 🫡🔥

@mcq_hack

On this record: Growth · Engagement · Reactions · Posts · Polls · Citations · Cite this entry

3,000subscribers

-6 since we began measuring on 13 August 2026

Risers and fallers across the register · movement among entries of 1,000–3,162.

Register entry

Telegram ID-1001839556113
TypeChannel
Username@mcq_hack
CreatedBetween 1 October 2022 and 30 September 2023— estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded13 August 2026
Last confirmed live17 August 2026
Measurements held3
Confirmed unchanged1 time, most recently 17 August 2026
On Telegramt.me/mcq_hack

Growth

3,0003,0063,00313 August 2026 — 3,006 subscribers13 August 2026 — 3,006 subscribers17 August 2026 — 3,000 subscribers13 August 202617 August 2026
3 measurements spanning 4 days, net -6. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 2,999–3,007 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
17 Aug 2026, 09:593,000-6
13 Aug 2026, 17:553,006no change
13 Aug 2026, 10:333,006first reading

Engagement

20 posts held, back to 12 May 2025the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 pageof Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 16 March 2026. An engagement rate over an empty window would be a number about nothing.

Reaction mix

61 reactions across 15 posts, in 7 distinct kinds. The most used accounts for 57.4% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
3557.4%
🔥914.8%
👍69.84%
❤‍🔥58.20%
46.56%
👏11.64%
😢11.64%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 15 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 61reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 20 most recent posts we hold, published 12 May 2025 to 16 March 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

16 Mar 2026, 12:09 UTC546 views2 reactionsread 13 August 2026
Forwarded from @OsmaIbra1

📌 مساء الخير حبايب تم فتح كورس مادة السريرية لصيادلتنا طلاب المرحلة الرابعة وبشكل مجاني بالكامل بعد ان كان الكورس مدفوع وبعد الترخيص من الاشخاص المقامين على هذا العمل تقرر فتحه بشكل مجاني للعامة لا تنسوهم من خالص دعائكم https://t.me/+ibUYhP582u1jYTky

1❤‍🔥1

Signed Osama I. Q.

17 May 2025, 17:44 UTC≈2,100 views3 reactionsread 13 August 2026
Forwarded from @ksoIee

دوزج فورم mcq جابتر New drug development https://t.me/ksoIiee/3758

👍21

Signed Mustafa Abd-Alzahra

12 May 2025, 22:07 UTC≈2,380 views8 reactionsread 13 August 2026
Forwarded from @ksoIee

5- human papillomavirus (HPV) --cervical cancers, 6- Epstein-Barr virus -- lymphomas 7- hepatitis B virus -- liver cancers 8- aniline -- bladder cancer 9- benzene -- leukemia 10- Anticancer agents such as the alkylating agents (eg, melphalan), anthracyclines (eg, doxorubicin), and epipodophyllotoxins (eg, etoposide) can cause secondary malignancies (eg, leukemias) years after therapy has been completed.

8

Signed Mustafa Abd-Alzahra

12 May 2025, 20:01 UTC≈1,850 views4 reactionsread 13 August 2026
Forwarded from @ksoIiee

كيسات Depressive Disorders 1- SSRIs 🟡 firstline antidepressants because of their relative safety in overdose and improved tolerability compared with earlier agents 🟢 Any antidepressant that enhances serotonergic activity can be associated with serotonin syndrome 🔵 Citalopram and escitalopram may to an increase in QT interval at doses above 40 mg/day. 2- SNRI 🟡 Venlafaxine may have a slight efficacy advantage compar

4

Signed Mustafa Abd-Alzahra

12 May 2025, 19:20 UTC985 views3 reactionsread 13 August 2026
Forwarded from @ksoIiee

كيسات ANXIETY DISORDERS 1- Paroxetine should be avoided in pregnancy (cardiovascular malformation risk) 2- SSIR and SNRIs and TCA يسببون jitteriness syndrome 3- fluoxetine, sertraline, or citalopram for pregnant 4- Intermediateor short acting benzodiazepines are preferred for chronic use in older patients 5- Benzodiazepine teratogenic “floppy baby syndrome,” and neonatal withdrawal 6- Diazepam and clorazepate

❤‍🔥21

Signed Mustafa Abd-Alzahra

12 May 2025, 18:51 UTC884 views4 reactionsread 13 August 2026
Forwarded from @ksoIiee

كيسات ALZHEIMER DISEASE 1- Cholinesterase Inhibitors a) Donepezil, rivastigmine, and galantamine for mild to moderate AD b)donepezil for severe AD 2- N Methyl D Aspartate (NMDA) Receptor Antagonist Memantine combination with a cholinesterase inhibitor and is indicated for moderate to severe AD 3- Anti amyloid Monoclonal Antibody aducanumab, lecanemab, donanemab, and gantenerumab aducanumab for cognitive impa

4

Signed Mustafa Abd-Alzahra

12 May 2025, 17:51 UTC837 views14 reactionsread 13 August 2026
Forwarded from @ksoIee

الادوية الي تسبب الادفرس افكت (كل سنة درجة لو درجتين حرامات يضيعن ) 1- Nausea and vomiting (Agents with a “high” emetic risk cause emesis in more than 90% of cases if not given any prophylaxis (such as cisplatin) 2- Mucositis taxanes, anthracyclines, platinum analogues, methotrexate, and the fluoropyrimidines. مرات يجيبون اسماء من عوائل الادوية ركزوا بيهم 3- Febrile neutropenia (FN) common adverse effect after adm

🔥94👍1

Signed Mustafa Abd-Alzahra

12 May 2025, 17:19 UTC896 views1 reactionsread 13 August 2026
Forwarded from @ksoIieePoll

of the following are effective strategies to prevent hemorrhagic cystitis in patients receiving cyclophosphamide or ifosfamide, EXCEPT:

  1. use Mesna (2-mercaptoethane sulfonate)25%
  2. give normal saline to Hyperhydration9%
  3. IV furosemide to maintain urine output8%
  4. bladder irrigation with catheterization8%
  5. Intravesical formalin instillation before chemotherapy50%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

👍1

Signed Mustafa Abd-Alzahra

12 May 2025, 17:12 UTC910 viewsread 13 August 2026
Forwarded from @ksoIieePoll

A 70-year-old man with refractory hemorrhagic cystitis reports severe pain unrelieved by NSAIDs. What is the next best step in pain management?

  1. use vasopressin with Hyperbaric oxygen therapy26%
  2. Perform immediate cystectomy7%
  3. Increase hydration6%
  4. Add antibiotics4%
  5. Initiate opioid analgesics and titrate to effect57%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

Signed Mustafa Abd-Alzahra

12 May 2025, 17:12 UTC769 views1 reactionsread 13 August 2026
Forwarded from @ksoIieePoll

A patient with hemorrhagic cystitis complains of severe bladder spasms. Which of the following medications is most appropriate to relieve her symptoms

  1. Ciprofloxacin12%
  2. Amitriptyline10%
  3. Oxybutynin70%
  4. Ranitidine3%
  5. Methotrexate6%

Shares as published, totalling 101%. No per-option vote count is published by Telegram, so none is shown.

1

Signed Mustafa Abd-Alzahra

12 May 2025, 17:12 UTC698 viewsread 13 August 2026
Forwarded from @ksoIieePoll

A patient with cyclophosphamide-induced cystitis continues to have hematuria despite local therapies. Which of the following systemic options is most appropriate?

  1. Methotrexate17%
  2. IV mannitol9%
  3. Loop diuretics14%
  4. Hyperbaric oxygen therapy48%
  5. prostaglandins12%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

Signed Mustafa Abd-Alzahra

12 May 2025, 16:04 UTC736 views4 reactionsread 13 August 2026
Forwarded from @ksoIiee

كيسات بروستات مهمة CRPC = castration resistant prostate cancer 1- patients with metastatic CRPC with symptomatic primary bone metastases (Radium223) 2- metastatic CRPC with BRCA1 and BRCA2 (olaparib and rucaparib) 3- improves survival in CRPC ( Docetaxel, combined with prednisone ) 4- improves progression free and overall survival in patients previously treated with docetaxel and prednisone (Cabazitaxel with pre

3👍1

Signed Mustafa Abd-Alzahra

Showing the 12 most recent of 20 posts we hold for @mcq_hack. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Polls

The 6 most recent of 8 polls we hold for this entry, as Telegram rendered them when we read the post. A poll’s figures keep moving after that, so each one is dated.

12 May 2025, 17:19 UTCAnonymous Quiz272 voters

of the following are effective strategies to prevent hemorrhagic cystitis in patients receiving cyclophosphamide or ifosfamide, EXCEPT:

  1. use Mesna (2-mercaptoethane sulfonate)25%
  2. give normal saline to Hyperhydration9%
  3. IV furosemide to maintain urine output8%
  4. bladder irrigation with catheterization8%
  5. Intravesical formalin instillation before chemotherapy50%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

12 May 2025, 17:12 UTCAnonymous Quiz267 voters

A patient with cyclophosphamide-induced cystitis continues to have hematuria despite local therapies. Which of the following systemic options is most appropriate?

  1. Methotrexate17%
  2. IV mannitol9%
  3. Loop diuretics14%
  4. Hyperbaric oxygen therapy48%
  5. prostaglandins12%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

12 May 2025, 17:12 UTCAnonymous Quiz263 voters

A patient with hemorrhagic cystitis complains of severe bladder spasms. Which of the following medications is most appropriate to relieve her symptoms

  1. Ciprofloxacin12%
  2. Amitriptyline10%
  3. Oxybutynin70%
  4. Ranitidine3%
  5. Methotrexate6%

Shares as published, totalling 101%. No per-option vote count is published by Telegram, so none is shown.

12 May 2025, 17:12 UTCAnonymous Quiz254 voters

A 70-year-old man with refractory hemorrhagic cystitis reports severe pain unrelieved by NSAIDs. What is the next best step in pain management?

  1. use vasopressin with Hyperbaric oxygen therapy26%
  2. Perform immediate cystectomy7%
  3. Increase hydration6%
  4. Add antibiotics4%
  5. Initiate opioid analgesics and titrate to effect57%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

12 May 2025, 15:14 UTCAnonymous Quiz321 voters

What is the most appropriate next step in her adjuvant treatment?

  1. Switch to tamoxifen only8%
  2. Start ado-trastuzumab emtansine (T-DM1)82%
  3. Continue trastuzumab for 1 year8%
  4. No further therapy needed1%

Shares as published, totalling 99%. No per-option vote count is published by Telegram, so none is shown.

12 May 2025, 14:58 UTCAnonymous Quiz316 voters

A 52-year-old woman is diagnosed with invasive ductal carcinoma of the breast. Her tumor measures 2.3 cm . Which of the following drug combinations is most appropriate as part of her adjuvant chemotherapy regimen?

  1. Ibrutinib and vincristine5%
  2. Letrozole and cyclophosphamide8%
  3. Doxorubicin and paclitaxel61%
  4. Tamoxifen and trastuzumab26%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

Percentages only — there are no per-option vote counts here, because Telegram publishes none.The public post preview gives each option’s share and a single voter total, and nothing else. Multiplying one by the other would produce a per-option tally that looks measured and is not: the shares are rounded to whole numbers before we ever see them. We print what was published and leave the column that does not exist empty.

The shares need not add up to 100.Rounding alone puts many polls at 99 or 101. A poll that allows more than one answer per voter runs well past 100 by design, and several here do. The bars are drawn against a fixed 100% track at each option’s own percentage rather than normalised to the total, so a poll that exceeds it shows that it does instead of being quietly rescaled.

Read from the 20 most recent posts we hold, published 12 May 2025 to 16 March 2026. Telegram labels each poll by kind — an anonymous poll, a quiz, a closed set of final results — and that label is reproduced rather than paraphrased.

Citation-graph rank

Citation-graph rank — 505,850 of 1,481,306entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Names

Channels on the register whose handles appear in this channel's posts.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 17 August 2026 — this entry's latest reading, not the date you are reading this.

“MCQ HACK 🫡🔥” (@mcq_hack), 3,000 subscribers as measured 17 August 2026. Telegram Register, tgregister.com/channel/mcq_hack.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.